BHWM
TXMD icon

Bay Harbor Wealth Management’s TherapeuticsMD TXMD Stock Holding History

Bay Harbor Wealth Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6
Closed -$1K – 414
2019
Q4 		$1K Hold
6
– – ﹤0.01% 328
2019
Q3 		$1K Hold
6
– – ﹤0.01% 346
2019
Q2 		$1K Hold
6
– – ﹤0.01% 342
2019
Q1 		$1K Hold
6
– – ﹤0.01% 376
2018
Q4 		$1K Buy
+6
New +$1.46K ﹤0.01% 369

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bay Harbor Wealth Management's TXMD Position: Q1 2020 in Review

Bay Harbor Wealth Management sold out of TherapeuticsMD (TXMD) in Q1 2020, closing a stake of 6 shares — an estimated $1K sold.

Bay Harbor Wealth Management first reported a position in TXMD in Q4 2018 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

  • Bay Harbor Wealth Management reported no remaining TherapeuticsMD position as of Q1 2020 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 6 TherapeuticsMD shares in Q1 2020, an estimated $1K.
  • Bay Harbor Wealth Management first reported a position in TherapeuticsMD in Q4 2018 and held it in 5 quarters.
  • Bay Harbor Wealth Management's TherapeuticsMD position peaked at $1K in Q4 2019.
  • 143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2020, filed 20 May 2020.